Thiamine Injection Shortage
Last Updated: June 2, 2021
Status: Resolved
Reason for the Shortage
-
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Mylan Institutional did not provide a reason for the shortage.
- Sagent had thiamine injection on shortage due to manufacturing delays.
Available Products
-
- Thiamine injection, Fresenius Kabi, 100 mg/mL, 2 mL vial, 25 count, NDC 63323-0013-02
- Thiamine injection, Hikma, 100 mg/mL, 2 mL vial, 25 count, NDC 00641-6228-25
- Thiamine injection, Mylan Institutional, 100 mg/mL, 2 mL vial, 25 count, NDC 67457-0196-02
- Thiamine injection, Sagent, 100 mg/mL, 2 mL vial, 25 count, NDC 25021-0500-02
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated June 2, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 13, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.